Blood clot prevention medicine during weight loss surgery
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether a blood-thinner medication (tinzaparin) can safely prevent dangerous blood clots in people with obesity who are having weight-loss surgery. The study happens at St Vincent's University Hospital in Dublin, Ireland.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a BMI of 40 or higher, OR a BMI of 35+ with a weight-related health condition like diabetes, high blood pressure, or sleep apnea
- You are scheduled for laparoscopic weight-loss surgery (sleeve gastrectomy or gastric bypass) at St Vincent's University Hospital in Dublin
- You are not currently taking blood-thinning medication for another condition
- You have no allergy to heparin or similar blood-thinner drugs
- You have normal kidney function and no known bleeding disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during weight loss surgery. If you are having a sleeve gastrectomy or mini-gastric bypass, taking TXA may lower your risk of hemorrhagic events.
This trial compares different blood clot prevention strategies for people over 18 with colorectal cancer who are having surgery lasting at least 45 minutes. It aims to find the best way to reduce the risk of dangerous blood clots after surgery.
This trial tests whether the drug tirzepatide (used for weight loss) can help reduce the return of atrial fibrillation after a catheter ablation procedure. It is for people with persistent AFib who are overweight and have another weight-related health condition.
This trial tests whether tirzepatide, a medication for weight and blood sugar, can reduce the chances of atrial fibrillation (an irregular heartbeat) coming back after a heart procedure called catheter ablation in people with overweight or obesity. It may help by addressing weight-related factors that contribute to heart rhythm problems.
This study compares two blood-thinning medications, rivaroxaban (a pill) and enoxaparin (a shot), to prevent dangerous blood clots after weight-loss surgery. If you are scheduled for bariatric surgery, this trial could help determine which approach works better for someone like you.
This study compares two different schedules of bemiparin (a blood thinner) to prevent dangerous blood clots after surgery in people with very high body weight. It may help find the safest and most effective dose/timing for clot prevention around the time of surgery.
Hear when a new Bariatric Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.